Clinical Trial Update: Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating immunogenicity, safety, and antibody persistence of different immunization strategies against Japanese encephalitis vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• Japanese Encephalitis Vaccine (Japanese Encephalitis vaccine)

Snippet

Sponsor: Liaoning Chengda Biotechnology CO., LTD | Conditions: Japanese Encephalitis Vaccine | Phase 4 | Status: ACTIVE_NOT_RECRUITING